Latest Dilution News

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Visionflex Group Limited reported a positive operating cash flow for the June 2025 quarter alongside revised convertible note facilities with key investors, signaling steady liquidity and funding stability.

Great Boulder Resources has released a scoping study for its Ironbark deposit within the Side Well Gold Project, highlighting a high-grade 100,000 oz resource and strong financial metrics that underpin a promising mining opportunity near Meekatharra, WA.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Caspin Resources has completed the second tranche of its $2.1 million capital raising, issuing shares and free-attaching options approved by shareholders. The move strengthens funding for its diverse Australian mineral projects.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Lefroy Exploration has secured a $2.5 million Profit Cash Advance Facility from BML Ventures, fully funding the Lucky Strike Gold Project through to profit-share distributions in early 2026 while avoiding shareholder dilution.

RBR Group Limited invites eligible shareholders to participate in a Share Purchase Plan aiming to raise up to $650,000 by offering shares at a highly discounted price of $0.001 each. The capital raised will support a joint venture, debt repayment, and working capital needs.